Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theralase AUA Poster

<< Previous

Bullboard Posts

Next >>

Comment by wildbird1on May 01, 2023 6:23pm

203 Views

Post# 35423862

RE:RE:RE:RE:RE:RE:RE:RE:Theralase AUA Poster

enriquesuave wrote: Hopefully they are working on a Partnership deal to get upfront cash to speed up trial and get started on next indications. If they raise $5 million that would be about 10% dilution. Not so bad for 10 -12 of cash months until a Partnership. Will it be a small raise or Partnership? Time will tell.

enriquasuave, speaking of money, we must not forget that if the SP climb over 0.50$ and stay over0.50$, all the warrant that are at 0.50$ and lower will be exercised, and in 2023,24 TLT could have secured approximately $35 million just in warrant money.

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand